3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Head & Neck
1
Conditions
Head and Neck Neoplasms
1
Deglutition Disorders
1
Communication Disorders
1
Interventions
Cisplatin
314
Radiotherapy
139
Cetuximab
133
pembrolizumab
131
Docetaxel
122
Carboplatin
119
Radiotherapy, Intensity-Modulated
97
Fluorouracil
94
Paclitaxel
92
Nivolumab
64
Gemcitabine
50
toripalimab
46
Radiation
44
Drug Therapy
39
Capecitabine
39
Magnetic Resonance Spectroscopy
38
Surgical Procedures, Operative
33
camrelizumab
31
130-nm albumin-bound paclitaxel
28
apatinib
27
tislelizumab
26
Chemoradiotherapy
26
Specimen Handling
25
Bevacizumab
24
durvalumab
23
Albumin-Bound Paclitaxel
23
nimotuzumab
22
lenvatinib
21
Sorafenib
21
Platinum
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lead
×
Head & Neck
×
Clear all
NCT02075385
2017-06-28
Swallowing-1
Barretos Cancer Hospital
Phase 2
Completed
94 enrolled